Abstract | INTRODUCTION: Triggering receptor expressed on myeloid cells (TREM) receptors and TREM-like transcript (TLT; or TREML) receptors of the immunoglobulin superfamily are known as key modulators of host immune responses. TREM-1 (CD354) and TREM-2 share the transmembrane adaptor DNAX-activation protein of 12 kDa (DAP12), but they possess separate stimulatory and inhibitory functional roles, especially in myeloid cells. AREAS COVERED: This review covers findings related to TREMs and TLTs published in patent applications from their discovery in 2000 to the present. New roles for TREM-1, TREM-2, TLT-1 and TLT-2 in maladies ranging from acute and chronic inflammatory disorders to cardiovascular diseases and cancers are discussed. Putative endogenous ligands and novel synthetic peptide blockers are also discussed. EXPERT OPINION: So far, therapeutic use of activators/blockers specific for TREMs and TLTs has been limited to preclinical animal models. TREM-1 is an immediate therapeutic target for acute and chronic inflammatory conditions, especially sepsis. Certain mutations in DAP12 and TREM-2 manifest into a disorder named polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, and newly identified TREM-2 variants confer a significant increase in risk of developing Alzheimer's disease. This makes TREM-2 an attractive therapeutic target for neurodegenerative diseases.
|
Authors | Christopher J Pelham, Amit N Pandya, Devendra K Agrawal |
Journal | Expert opinion on therapeutic patents
(Expert Opin Ther Pat)
Vol. 24
Issue 12
Pg. 1383-95
(Dec 2014)
ISSN: 1744-7674 [Electronic] England |
PMID | 25363248
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
|
Chemical References |
- Membrane Glycoproteins
- Receptors, Immunologic
- TREM-2a receptor
- TREM-2b receptor
- TREM1 protein, human
- TREML1 protein, human
- TREML4 protein, human
- Trem3 protein, mouse
- Triggering Receptor Expressed on Myeloid Cells-1
|
Topics |
- Animals
- Humans
- Membrane Glycoproteins
(drug effects, physiology)
- Patents as Topic
- Receptors, Immunologic
(drug effects, physiology)
- Triggering Receptor Expressed on Myeloid Cells-1
|